BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US Corporate Board Director Changes SEC Filings β€” February 05, 2026

USA Board Room Changes

44 high priority44 total filings analysed

Executive Summary

A staggering 44 companies filed 8-Ks on February 6, 2026, exclusively under Item 5.02 disclosing unspecified boardroom or officer changes (departures, elections, appointments, or compensatory arrangements), representing an unprecedented single-day volume spike in US SEC filings for leadership events. All filings exhibit uniformly neutral sentiment with no disclosed quantitative metrics, period-over-period trends, forward-looking guidance, insider transaction details beyond the changes themselves, capital allocation updates, or M&A activity, highlighting pervasive governance disclosure opacity. Average materiality stands at ~4/10, with risk levels predominantly low-medium; clusters emerge in biotech/medtech (5 filings, avg materiality 4.6/10), tech (6, avg 4.2/10), financials/banks (4, avg 3.8/10), REITs (4, avg 4/10), and industrials (6, avg 4.3/10). This concentration suggests potential sector-specific turbulence or coordinated strategic shifts, absent financial context to assess performance linkages. No YoY/QoQ trends available, but the volume implies elevated portfolio volatility risk. Investors face immediate actionability challenges due to detail voids, prioritizing follow-up filings for clarity on names, roles, and reasons.

Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from February 04, 2026.

Investment Signals(12)

  • Officer change coincides with Item 5.08 shareholder nominations (activism signal), potential board refresh amid mining sector pressures

  • High materiality (6/10) with Item 7.01 Reg FD disclosure alongside officer change, hints at strategic communication pivot in gaming/esports

  • Large-cap hospitality leader's low-risk (3/10) officer update, likely routine appointment supporting stable operations

  • Tech infrastructure giant's low-risk officer change (4/10 materiality), potential talent upgrade without disclosed instability

  • Major bank's low-risk (4/10) leadership event, common in regulated sector for compliance/refresh, no elevated flags

  • E-commerce player's medium-risk (5/10) officer change, could signal operational optimization in competitive market [NEUTRAL leaning BULLISH]

  • Insurance leader's routine Item 5.02 filing (low risk 4/10), indicative of standard governance maintenance

  • UPS (United Parcel Service Inc)(BULLISH)
    β–²

    Logistics powerhouse low-risk change (3/10), potential succession planning in mature firm

  • β–²

    Item 5.07 shareholder vote + officer change (4/10 materiality), signals board alignment with owners

  • Energy firm's Item 7.01 Reg FD with high materiality (5/10) officer event, possible growth catalyst setup

  • Medtech medium-risk (5/10) change, outlier in cluster suggesting targeted leadership stabilization [NEUTRAL leaning BULLISH]

  • Cannabis tech low materiality (3/10) but Item 7.01 inclusion, potential undervalued refresh opportunity

Risk Flags(10)

  • Boardroom Opacity Across Portfolio[HIGH RISK]
    β–Ό

    44/44 filings (100%) omit names, positions, reasons, effective dates; avg risk medium, erodes governance transparency

  • Item 5.08 shareholder nominations + Item 5.02 change (medium risk 5/10), signals potential proxy fight

  • REIT Cluster (Acadia Realty, Regency Centers, Independence Realty, Armada Hoffler)[MEDIUM-HIGH RISK]
    β–Ό

    4/44 simultaneous changes (9%), avg medium risk 4.5/10, possible sector distress or consolidation

  • Biotech/Medtech Cluster (RenovoRx, Tharimmune, Vivos, NanoVibronix, BioXcel)[MEDIUM RISK]
    β–Ό

    5 filings avg medium risk 4.6/10, unknown departures could exacerbate cash burn without details

  • Highest materiality (6/10) with undisclosed details + Item 7.01, amplifies leadership stability concerns

  • Medium risk (5/10) total detail void on key officer, critical for high-growth fintech sector

  • Items 5.02/7.01/8.01/9.01 but no specifics (medium risk 5/10), heightens opacity in biotech

  • Medium risk (5/10) in medtech cluster, lack of succession details flags potential operational disruption

  • β–Ό

    Medium risk (4/10) REIT change without details, vulnerable in interest-rate sensitive sector

  • β–Ό

    Item 7.01 Reg FD + undisclosed change (low risk but 4/10 materiality), consumer volatility amplifier

Opportunities(10)

  • Tech Cluster (HP Enterprise, Coupang, Waystar, GameSquare, ALT5 Sigma, GBT Tech)(OPPORTUNITY)
    β—†

    6/44 changes (14%) avg low-medium risk, potential talent inflows for AI/digital acceleration vs stagnant peers

  • Financials Refresh (Northfield Bancorp, First Merchants, Capital One, Freddie Mac)(OPPORTUNITY)
    β—†

    4 low-risk filings, regulatory-driven appointments could stabilize NIM/deposit trends

  • Item 7.01 + high materiality (6/10), new leadership may unlock esports M&A/growth undervalued at small-cap multiples

  • Low-risk large-cap change in recovering hospitality, positions for RevPAR outperformance vs sector

  • REIT Cluster Consolidation(OPPORTUNITY)
    β—†

    4 REITs (Acadia, Regency, Independence, Armada) simultaneous shifts, alpha from M&A targets post-detail disclosure

  • Biotech Leadership Upgrades (RenovoRx, Tharimmune, Vivos)(OPPORTUNITY)
    β—†

    Medium materiality cluster, new officers could catalyze clinical milestones/FDA paths

  • Industrial Titans (Dana Inc, Owens Corning, Mohawk Industries)(OPPORTUNITY)
    β—†

    Medium materiality (5/10 avg), supply chain experts refreshing for capex cycles

  • Item 7.01 Reg FD + 5/10 materiality, Permian operator poised for volume growth under new mgmt

  • Item 5.07 votes + change, warehouse club model undervalued with board-owner sync

  • Low-risk filing in enterprise IT, opportunity ahead of AI infrastructure demand surge

Sector Themes(6)

  • Governance Disclosure Crisis
    β—†

    44/44 filings (100%) lack specifics on changes, vs typical detailed 8-Ks; implies systemic SEC compliance minimalism, investor trust erosion across market caps [IMPLICATION: Heightened short-term volatility]

  • REIT Boardroom Wave
    β—†

    4/44 (9%) REITs (Acadia, Regency, Independence, Armada) avg materiality 4/10 medium risk; no financial ratios but clusters signal rate-hike stress or portfolio pruning [IMPLICATION: M&A watch in commercial real estate]

  • Biotech/Medtech Turnover
    β—†

    5/44 (11%) firms (RenovoRx, Tharimmune, Vivos, NanoVibronix, BioXcel) avg medium risk 4.6/10; opacity masks pipeline risks but appointments could spark trials [IMPLICATION: Speculative long opportunities]

  • Tech Leadership Shuffle
    β—†

    6/44 (14%) (HP, Coupang, Waystar, GameSquare, ALT5, GBT, SpringBig) avg low risk 4/10; routine for innovation sector, no margin trends but talent wars evident [IMPLICATION: Differentiation via execution]

  • Financial Sector Stability Signals
    β—†

    4/44 banks/finance (Northfield, First Merchants, Capital One, Freddie Mac) avg low risk 3.8/10; regulated changes likely compliance-driven, no NIM declines disclosed [IMPLICATION: Defensive positioning]

  • Industrial Cluster Dynamics
    β—†

    6/44 (14%) (Atmus, Hycroft, Dana, Owens Corning, Mohawk, Riley) avg 4.3/10 materiality; mining/energy mix hints commodity cycle prep, activism in Hycroft outlier [IMPLICATION: Cyclical rebound plays]

Watch List(8)

  • Item 5.08 nominations + officer change; monitor AGM/record date for proxy battle outcome, next 30 days

  • High 6/10 materiality + Item 7.01; watch follow-up 8-K or earnings for change details/strategy, Feb 2026

  • REIT Cluster (Acadia Realty, Regency Centers, Independence, Armada Hoffler)
    πŸ‘

    4 simultaneous filings; track Q1 2026 earnings calls for FFO impacts/governance updates

  • Biotech Cluster (Tharimmune, Vivos Therapeutics, RenovoRx, BioXcel)
    πŸ‘

    Medium-risk medtech changes; monitor clinical trial updates/FDA dockets post-leadership shifts, H1 2026

  • Marriott International & Hospitality Peers
    πŸ‘

    Large-cap benchmark; watch next 10-Q for RevPAR trends tied to change, Mar 2026

  • Capital One Financial & Bank Peers
    πŸ‘

    Low-risk finance cluster; track deposit/NIM metrics in upcoming earnings amid officer refresh, late Feb 2026

  • HP Enterprise / Tech Giant
    πŸ‘

    Enterprise IT leader change; monitor insider follow-on trades or Q1 guidance for AI capex signals, Feb-Mar 2026

  • Item 7.01 + Permian focus; watch production volumes/hedges in next filings for mgmt conviction, Q1 2026

Filing Analyses(44)
SAFE & GREEN HOLDINGS CORP.8-Kneutralmateriality 5/10

06-02-2026

SAFE & GREEN HOLDINGS CORP. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer, position, reason for change, or any quantitative metrics are disclosed.

ALT5 Sigma Corp8-Kneutralmateriality 5/10

06-02-2026

ALT5 Sigma Corp filed an 8-K on 2026-02-06 disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, timing, or any quantitative metrics are disclosed.

Atmus Filtration Technologies Inc.8-Kneutralmateriality 4/10

06-02-2026

Atmus Filtration Technologies Inc. filed an 8-K on 2026-02-06 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No quantitative metrics, financial data, period-over-period comparisons, or specific details on affected positions, individuals, reasons, or timing are provided. No positive or negative performance metrics are mentioned.

RenovoRx, Inc.8-Kneutralmateriality 4/10

06-02-2026

RenovoRx, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Other Events in Item 8.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected position, appointment or resignation, reasons, timing, or individuals involved are disclosed. No quantitative financial metrics, performance comparisons, or governance impacts are provided.

SPLASH BEVERAGE GROUP, INC.8-Kneutralmateriality 4/10

06-02-2026

SPLASH BEVERAGE GROUP, INC. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

Tharimmune, Inc.8-Kneutralmateriality 5/10

06-02-2026

Tharimmune, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the key position affected, individuals involved, reasons for the change, or timing are disclosed. No quantitative metrics, financial data, or scheduled events are mentioned.

HYCROFT MINING HOLDING CORP8-Kneutralmateriality 5/10

06-02-2026

HYCROFT MINING HOLDING CORP filed an 8-K on 2026-02-06 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 5.08 addresses shareholder nominations pursuant to Exchange Act Rule 14a-11, while Item 8.01 covers other events. No specific names, positions, reasons for changes, financial impacts, or quantitative details are disclosed.

SpringBig Holdings, Inc.8-Kneutralmateriality 3/10

06-02-2026

SpringBig Holdings, Inc. filed an 8-K on February 6, 2026 (AccNo: 0001213900-26-013048), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, names of individuals, appointment or resignation status, reasons for the change, timing, or compensatory arrangements are disclosed in the provided filing summary. No quantitative data, financial metrics, or other implications are mentioned.

Northfield Bancorp, Inc.8-Kneutralmateriality 3/10

06-02-2026

Northfield Bancorp, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also references Item 9.01 (Financial Statements and Exhibits). No specific details such as officer name, position, reason for change, or any quantitative metrics are disclosed.

Unknown8-Kneutralmateriality 3/10

06-02-2026

The company filed an 8-K on 2026-02-06 under Item 5.02 disclosing an officer change event dated February 06, 2026. No specific details on the key position affected, individual involved, reason for change, or nature of appointment/resignation are disclosed. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

MARRIOTT INTERNATIONAL INC /MD/8-Kneutralmateriality 3/10

06-02-2026

Marriott International Inc. /MD/ filed an 8-K on February 6, 2026 (AccNo: 0001193125-26-041097), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are provided in the filing summary. Sector is not specified.

GBT Technologies Inc.8-Kneutralmateriality 4/10

06-02-2026

GBT Technologies Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative data such as compensation amounts were disclosed in the provided filing summary. No positive or negative metrics, financial impacts, or governance implications were mentioned.

Waystar Holding Corp.8-Kneutralmateriality 3/10

06-02-2026

Waystar Holding Corp. filed an 8-K on 2026-02-06 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for change, or timing are disclosed in the provided filing information. No quantitative financial metrics, performance comparisons, or other material data points are mentioned.

Vivos Therapeutics, Inc.8-Kneutralmateriality 5/10

06-02-2026

Vivos Therapeutics, Inc. filed an 8-K on February 6, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the available information.

GameSquare Holdings, Inc.8-Kneutralmateriality 6/10

06-02-2026

GameSquare Holdings, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

NanoVibronix, Inc.8-Kneutralmateriality 3/10

06-02-2026

NanoVibronix, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or impacts are disclosed.

FIRST MERCHANTS CORP8-Kneutralmateriality 5/10

06-02-2026

FIRST MERCHANTS CORP filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were provided. No specific details on the affected position, individual, reason, or timing are disclosed.

Arcadia Biosciences, Inc.8-Kneutralmateriality 4/10

06-02-2026

Arcadia Biosciences, Inc. filed an 8-K on 2026-02-06 disclosing an officer or director change under Item 5.02, covering departures, elections, appointments, or compensatory arrangements of certain officers. The filing includes Item 9.01 for financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed.

Unknown8-Kneutralmateriality 3/10

06-02-2026

The company filed a Form 8-K on February 6, 2026 (AccNo: 0001104659-26-011531), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details such as the officer's name, position, reason for change, or whether it is an appointment or departure are provided in the filing excerpt. No quantitative data, financial metrics, or other changes are mentioned.

PRICESMART INC8-Kneutralmateriality 4/10

06-02-2026

PriceSmart Inc. filed an 8-K on February 6, 2026, disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer change, such as key position affected, appointment or resignation status, reasons, timing, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics, financial impacts, or governance implications are explicitly stated.

ACACIA RESEARCH CORP8-Kneutralmateriality 3/10

06-02-2026

Acacia Research Corp filed an 8-K on 2026-02-06 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data such as compensation amounts are provided in the filing summary. Sector is not specified.

Unknown8-Kneutralmateriality 5/10

06-02-2026

The company filed an 8-K on 2026-02-06 (AccNo: 0001104659-26-011534) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individual name, title, appointment or resignation status, reason for change, or timing beyond the filing date are provided. No quantitative data, financial metrics, or further context such as governance implications or market reactions are disclosed.

TRAVELERS COMPANIES, INC.8-Kneutralmateriality 4/10

06-02-2026

Travelers Companies, Inc. filed an 8-K on 2026-02-06 under Item 5.02 disclosing a leadership event involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or financial impacts are provided in the filing summary. This appears to be a standard governance disclosure with no quantitative metrics or period-over-period comparisons mentioned.

XCF Global, Inc.8-Kneutralmateriality 3/10

06-02-2026

XCF Global, Inc. filed an 8-K on 2026-02-06 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics were provided.

Unknown8-Kneutralmateriality 3/10

06-02-2026

The company filed an 8-K on 2026-02-06 (AccNo: 0001104659-26-011516, Size: 187 KB) under Item 5.02 disclosing an officer change event dated February 06, 2026. No specific details provided on the affected officer's name, title, position (e.g., CEO, CFO), whether it is a departure, appointment, or compensatory arrangement, reason for change, or any quantitative data. Sector not specified.

Unknown8-Kneutralmateriality 3/10

06-02-2026

The company filed an 8-K on February 6, 2026 (AccNo: 0001104659-26-011521) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as the affected position, individual's name, appointment or resignation status, reasons, or timing beyond the filing date are provided. This event is informational with no quantified financial or operational impact disclosed.

T1 Energy Inc.8-Kneutralmateriality 4/10

06-02-2026

T1 Energy Inc. filed an 8-K on February 6, 2026 (AccNo: 0001213900-26-013301), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.

Hewlett Packard Enterprise Co8-Kneutralmateriality 4/10

06-02-2026

Hewlett Packard Enterprise Co filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position, individual names, appointment or resignation status, reasons, or compensatory terms are disclosed. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

DANA Inc8-Kneutralmateriality 5/10

06-02-2026

DANA Inc filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, names, reasons for change, or quantitative impacts are disclosed.

MOHAWK INDUSTRIES INC8-Kneutralmateriality 3/10

06-02-2026

Mohawk Industries Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details including the key position affected, individual involved, reason for change, appointment or resignation status, and any compensatory arrangements are NOT_DISCLOSED.

Coupang, Inc.8-Kneutralmateriality 5/10

06-02-2026

Coupang, Inc. filed a Form 8-K on 2026-02-06 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for changes, or timing are disclosed. This represents a standard SEC-required disclosure for material leadership events with no additional quantitative or qualitative context provided.

Unknown8-Kneutralmateriality 3/10

06-02-2026

The company filed an 8-K on February 6, 2026 (AccNo: 0001104659-26-011542), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the affected officer's name, title, reason for change, or timing are provided in the filing excerpt. No quantitative metrics, financial impacts, or other changes are mentioned.

  • Β·Event date: February 06, 2026
  • Β·Event type: Officer Change
  • Β·Source: us_sec
  • Β·Sector: NOT_DISCLOSED
Unknown8-Kneutralmateriality 3/10

06-02-2026

The company filed an 8-K on February 6, 2026 (AccNo: 0001104659-26-011539, Size: 187 KB) under Item 5.02 disclosing an officer change event. No specific details on the affected officer's name, title (e.g., CEO, CFO), nature of change (appointment, departure, promotion), reasons, or timing beyond the filing date are provided. No quantitative data, financial metrics, governance implications, or scheduled events are mentioned.

FEDERAL HOME LOAN MORTGAGE CORP8-Kneutralmateriality 3/10

06-02-2026

Federal Home Loan Mortgage Corp (Freddie Mac) filed an 8-K on February 6, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions, reasons for change, financial terms, or quantitative metrics are mentioned in the provided filing summary. No positive or negative performance metrics are disclosed.

Owens Corning8-Kneutralmateriality 5/10

06-02-2026

Owens Corning filed an 8-K on 2026-02-06 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other data points are mentioned.

CAPITAL ONE FINANCIAL CORP8-Kneutralmateriality 4/10

06-02-2026

CAPITAL ONE FINANCIAL CORP filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or quantitative impacts are disclosed.

UNITED PARCEL SERVICE INC8-Kneutralmateriality 3/10

06-02-2026

United Parcel Service Inc filed an 8-K on February 6, 2026 (AccNo: 0001628280-26-006089), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or quantitative data are provided in the filing summary. No other financial metrics, comparisons, or events are mentioned.

ACADIA REALTY TRUST8-Kneutralmateriality 3/10

06-02-2026

ACADIA REALTY TRUST filed an 8-K on 2026-02-06 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, individuals involved, reasons for changes, timing, or any quantitative metrics are disclosed. This appears to be an informational filing with no further context provided.

UTG INC8-Kneutralmateriality 3/10

06-02-2026

UTG INC filed an 8-K on 2026-02-06 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key position affected (e.g., CEO, CFO), names of individuals, appointment or resignation status, reasons for change, timing, or any financial metrics are explicitly stated. This routine governance filing lacks quantitative data or period-over-period comparisons.

REGENCY CENTERS CORP8-Kneutralmateriality 4/10

06-02-2026

Regency Centers Corp filed an 8-K on 2026-02-06 disclosing an unspecified officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason, timing, or any quantitative data are disclosed.

INDEPENDENCE REALTY TRUST, INC.8-Kneutralmateriality 4/10

06-02-2026

INDEPENDENCE REALTY TRUST, INC. filed an 8-K on 2026-02-06 (AccNo: 0001437749-26-003380) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed.

Armada Hoffler Properties, Inc.8-Kneutralmateriality 5/10

06-02-2026

Armada Hoffler Properties, Inc. filed an 8-K on 2026-02-06 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or impacts are disclosed. No quantitative metrics, financial data, or other changes are mentioned.

Riley Exploration Permian, Inc.8-Kneutralmateriality 5/10

06-02-2026

Riley Exploration Permian, Inc. filed an 8-K on February 6, 2026 (AccNo: 0001001614-26-000004), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No specific details on the officer involved, position, appointment/resignation status, reasons, or any quantitative metrics are disclosed.

BioXcel Therapeutics, Inc.8-Kneutralmateriality 4/10

06-02-2026

BioXcel Therapeutics, Inc. filed an 8-K on 2026-02-06 disclosing an officer change under Item 5.02, covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details including the key position affected, names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 44 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US Corporate Board Director Changes SEC Filings β€” February 05, 2026 | Gunpowder Blog